Gianfe1
Nuovo Utente
- Registrato
- 15/1/09
- Messaggi
- 1.674
- Punti reazioni
- 29
15,8 ok!ok!ok!ok!
dai ragazzi non scherzate sempre!!! mi fate venire un coccolone!!!!
Follow along with the video below to see how to install our site as a web app on your home screen.
Nota: This feature may not be available in some browsers.
15,8 ok!ok!ok!ok!
dai ragazzi non scherzate sempre!!! mi fate venire un coccolone!!!!
A quella cifra faccio un busto in bronzo di kyro e lo metto in salone.
Roche o Pfizer, entro l'anno l'accordo. La Merck punta sulla diabetologia, cardiologia e neurologia. Non credo sappia niente sull'AE37.
Mi sa che non ce la facciamo....
A quella cifra faccio un busto in bronzo di kyro e lo metto in salone.
Dilettante!io vado a prendere Kyro e lo mummifico in salotto in posa plastica!
Form 8-K for GENEREX BIOTECHNOLOGY CORP
23-Dec-2011
Other Events
Item 8.01. Other Events.
During the period July 1 through November 30, 2011 Generex Biotechnology Corporation (the" Company") issued, pursuant to a contractual commitment, 750,000 shares of common stock, in the aggregate, to a consultant for services rendered. The shares issued were valued at $0.09 to $0.13 per share based on the quoted market price of the Company's common stock on the designated dates of the issuances. All of the shares were issued without registration and, thereofore, were subject to restrictions on transfer. To avoid the consequences of the issuance of such shares at low attributed prices, the consultant has agreed to return the shares for cancellation on the following terms. The Company will issue to the consultant a promissory note in the principal amount of $116,250, due December 31, 2012, with interest payable at 10% per annum. The consultant, at its option, may convert the principal and accrued interest into the Company's common stock at a conversion price equal to 85% of the current market price of the shares, provided that the note may not be converted into shares at a price lower than $.15 per share.
Summary of GENEREX BIOTECHNOLOGY CORP - Yahoo! Finance
si0.173 - 1.96 M
sbaglio o è un gran bel risultato in questo nostro contesto?
buona pure questa, anchs e non pesava molto, ma tutto fa brodoForm 8-K for GENEREX BIOTECHNOLOGY CORP
23-Dec-2011
Other Events
Item 8.01. Other Events.
During the period July 1 through November 30, 2011 Generex Biotechnology Corporation (the" Company") issued, pursuant to a contractual commitment, 750,000 shares of common stock, in the aggregate, to a consultant for services rendered. The shares issued were valued at $0.09 to $0.13 per share based on the quoted market price of the Company's common stock on the designated dates of the issuances. All of the shares were issued without registration and, thereofore, were subject to restrictions on transfer. To avoid the consequences of the issuance of such shares at low attributed prices, the consultant has agreed to return the shares for cancellation on the following terms. The Company will issue to the consultant a promissory note in the principal amount of $116,250, due December 31, 2012, with interest payable at 10% per annum. The consultant, at its option, may convert the principal and accrued interest into the Company's common stock at a conversion price equal to 85% of the current market price of the shares, provided that the note may not be converted into shares at a price lower than $.15 per share.
Summary of GENEREX BIOTECHNOLOGY CORP - Yahoo! Finance
Buon Natale e tutti! Ci risentiamo martedì!!!
E' martedi'!!!!!!!!!!!!!!!!!
troppo spumante
si è positiva!
Buon Natale e tutti!!
sotto i 10 in prossimità del triplo mini o rientro anche io